
|Podcasts|March 15, 2018
Episode 4: Outcomes-Based Contracting
Author(s)Michelle Maskaly, Christen Harm
In this episode, Michelle and Christen talk to Editor-in-Chief Lisa Henderson and European Editor Julian Upton about outcomes-based contracting from the March issue.
Advertisement
In this episode, Michelle and Christen talk to Editor-in-Chief Lisa Henderson and European Editor Julian Upton about outcomes-based contracting from the March issue.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
3
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
4
FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV, Mounjaro to Reduce MACE in Adults with Type 2 Diabetes
5
